About Hemarus
Hemarus is a company based in Hyderabad (India) founded in 2003 was acquired by Olam Agro in August 2011. The company has 68 employees as of March 31, 2024. Hemarus operates in a competitive market with competitors including Editas Medicine, GBT, LogicBio, Kedrion and Modus Therapeutics, among others.
- Headquarter Hyderabad, India
- Employees 68 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hemarus Therapeutics Limited
- Date of Incorporation 16 Sep, 2003
- Jurisdiction Shaikpet, Telangana, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Hemarus
Detailed funding history for Hemarus
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Hemarus
Hemarus has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Olam Agro.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of farm gate sourcing-based processing and selling solutions for farmers
|
Locked | Locked | Locked |
Investor details for Hemarus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hemarus
Investment portfolio details for Hemarus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Hemarus
Detailed financials for Hemarus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hemarus Comparisons
Peer comparison for Hemarus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hemarus
Hemarus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Editas Medicine, GBT, LogicBio, Kedrion and Modus Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for rare genetic diseases are developed using CRISPR technology.
|
|
| Locked | Locked | Locked |
Small molecules are developed for sickle cell disease treatment.
|
|
| Locked | Locked | Locked |
Viral vectors are developed for genetic and infectious disease treatments.
|
|
| Locked | Locked | Locked |
Plasma-derived therapies are developed for hemophilia and immune deficiencies.
|
|
| Locked | Locked | Locked |
Polysaccharide-based drug for Sickle Cell Disease treatment is developed.
|
|
| Locked | Locked | Locked |
Therapies for sickle cell disease and diabetic nephropathy are developed.
|
Detailed competitors of Hemarus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hemarus
Complete news archive for Hemarus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemarus
Hemarus was founded in 2003.
Hemarus is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2024, the latest employee count at Hemarus is 68.
Annual revenue of Hemarus is $853.5K as on Mar 31, 2022.
Hemarus is an Indian Pharma manufacturer of plasma-derived biopharmaceuticals for bleeding disorders. Their products include human albumin, immunoglobulins, coagulation factor, fibrin sealant etc. Their plant has a capacity to process 130,000 litres of plasma annually.
Hemarus's top competitors include GBT, Editas Medicine and Kedrion.
Hemarus has 1 investor. Key investors include Olam Agro.